Risk prediction models for venous thromboembolism among patients with multiple myeloma: a systematic review and meta-analysis
PeerJ · 26.05.2026 · 14 · e21322
DOI: 10.7717/peerj.21322 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PeerJ, online erschienen am 26.05.2026. Verfasst von Jin Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Venous Thromboembolism. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science & Technology Programme of the Sichuan Provincial Health Commission, Mianyang Philosophy and Social Science Research Program.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Background
Risk prediction models help identify multiple myeloma (MM) patients at high risk of venous thromboembolism (VTE) and guide clinical decisions. However, their applicability and accuracy remain unclear. This study aims to systematically review existing VTE risk models in MM patients.
Methods
We systematically searched PubMed, Embase, Cochrane Library, and Web of Science for studies on VTE risk prediction models in patients with MM, up to March 31, 2026. Two investigators independently screened the literature, extracted data, and assessed the risk of bias and applicability of the included studies using the PROBAST tool. Data analysis was performed using the “meta” and “metafor” packages in R software.
Results
A total of 14 studies on VTE risk prediction models in MM patients were included, involving the development and/or validation of seven risk assessment tools. Meta-analysis showed that the overall VTE incidence in MM patients was 7.9% (95% CI [6.2–10.1%]). The combined area under the curve (AUCs) of the seven tools ranged from 0.57 to 0.68, with the IMPEDE VTE and IMPEDED VTE scores showing the best performance. Only two studies used the Hosmer-Lemeshow test for model calibration, and all studies presented the models in formula form. All included studies were at high risk of bias, mainly in the outcome and analysis domains.
Conclusion
Existing VTE risk models for MM patients show low predictive performance (pooled AUC < 0.7) and limited clinical use. Future research should focus on model updating and external validation to improve accuracy and applicability. PROSPERO Registration number ID: CRD420251024346.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, China.
- Department of Oncology, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, China.
- Department of Oncology, Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
- Department of Cardiology, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, China.
- Department of Cerebrovascular Surgery, Sichuan Mianyang 404 Hospital, Mianyang, Sichuan, China.
Förderung
- Science & Technology Programme of the Sichuan Provincial Health Commission
- Mianyang Philosophy and Social Science Research Program
Zitieren
APA
Yang, J., Pu, Y., Li, Y., Li, X., Jiang, X., & Zou, L. (2026). Risk prediction models for venous thromboembolism among patients with multiple myeloma: a systematic review and meta-analysis. PeerJ, 14, e21322. https://doi.org/10.7717/peerj.21322
Vancouver
Yang J, Pu Y, Li Y, Li X, Jiang X, Zou L. Risk prediction models for venous thromboembolism among patients with multiple myeloma: a systematic review and meta-analysis. PeerJ. 2026;14:e21322. doi:10.7717/peerj.21322
BibTeX
@article{Yang2026,
author = {Yang, Jin and Pu, You and Li, Yuqin and Li, Xuelian and Jiang, Xia and Zou, Liping},
title = {Risk prediction models for venous thromboembolism among patients with multiple myeloma: a systematic review and meta-analysis},
journal = {PeerJ},
year = {2026},
volume = {14},
pages = {e21322},
doi = {10.7717/peerj.21322}
}
EUVIMED